Midas Hospitality selects Broadvine to optimize performance

Midas properties will be able to easily view and analyze data to make quicker, more profitable decisions.

Midas Hospitality is implementing Broadvine’s cloud-based business-intelligence and analytics application to optimize hotel portfolio performance. Broadvine’s application delivers business intelligence insights via reporting, forecasting, labor and expense management to hotel management companies worldwide. By consolidating data from various property-management systems, benchmarking and labor systems, in combination with their accounting platform, Midas will be able to easily view and analyze data to make quicker, more profitable decisions.

“Broadvine’s suite of modules will enable us to easily assess our performance and operational efficiencies, enabling our team to drive profitability while spending more time with our guests,” Jim Brueggermann, CFO of Midas Hospitality, said in a statement. “Using technology to improve our results to our ownership partners and delivering an exceptional guest experience is key to our continued growth and success.”

Broadvine CEO Shawn Barber said Broadvine’s mission is to enable its partners to deliver an exceptional guest experience by eliminating the time and frustration associated with aggregating and manipulating data into reports and insights.


Like this story? Subscribe to Technology!

Hospitality professionals turn to Technology as their go-to news source for the latest technology products and trends. Sign up today to get news and updates on security systems, in-room entertainment, and more delivered to your inbox and read on the go.

Suggested Articles

The first hurricane of the season, now on its way out of Louisiana, failed to bring the extreme flooding meteorologists feared it would.

The new appointments come as Access Point Financial plans to significantly expand its portfolio of financial programs.

The 285-key 1 West Hollywood marks the brand’s first hotel on the West Coast and its fourth hotel overall.